Role of the rabbit whole-heart model for electrophysiologic safety pharmacology of non-cardiovascular drugs
- 17 November 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 23 (6) , 828-836
Abstract
Plenty of non-cardiovascular drugs alter cardiac electrophysiology and may ultimately lead to life-threatening arrhythmias. In clinical practice, measuring the QT interval as a marker for the repolarization period is the most common tool to assess the electrophysiologic safety of drugs. However, the sole measurement of the QT interval may be insufficient to determine the proarrhythmic risk of non-cardiovascular agents. Several other markers are considered in pre-clinical safety testing to determine potential harm on cardiac electrophysiology. Besides measuring typical electrophysiologic parameters such as repolarization duration, whole-heart models allow the determination of potential predictors for proarrhythmia. Spatial and temporal heterogeneity as well as changes of shape of the action potential can be easily assessed. In addition, provocation manoeuvers (either by electrolyte imbalances or programmed pacing protocols) may induce sustained arrhythmias and thereby determine ventricular vulnerability to arrhythmias. Compared with the human heart, the rabbit heart possesses a similar distribution of ion currents that govern cardiac repolarization, resulting in a rectangular action potential configuration in both species. In addition, similar biophysical properties of rabbit and human cardiac ion channels lead to a comparable pharmacologic response in human and rabbit hearts. Of note, arrhythmia patterns resemble in both species due to the similar effective size of human and rabbit hearts. Thus, the rabbit heart is particularly suitable for testing the electrophysiologic safety of drugs. Several experimental setups have been developed for studying cardiac electrophysiology in rabbits, ranging from single cell to tissue preparations, whole-heart setups, and in vivo models.Keywords
This publication has 112 references indexed in Scilit:
- Electrophysiological studies of transgenic long QT type 1 and type 2 rabbits reveal genotype-specific differences in ventricular refractoriness and His conductionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Transmural Dispersion of Repolarization in Failing and Nonfailing Human VentricleCirculation Research, 2010
- Drug‐induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectivesBritish Journal of Pharmacology, 2010
- Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarizationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjectsBritish Journal of Clinical Pharmacology, 2008
- Predicting drug‐induced changes in QT interval and arrhythmias: QT‐shortening drugs point to gaps in the ICHS7B GuidelinesBritish Journal of Pharmacology, 2008
- Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndromeHeart Rhythm, 2008
- Combined pharmacological block of IKr and IKs increases short‐term QT interval variability and provokes torsades de pointesBritish Journal of Pharmacology, 2007
- Does Tpeak–Tend provide an index of transmural dispersion of repolarization?Heart Rhythm, 2007
- A Rabbit Langendorff Heart Proarrhythmia Model: Predictive Value for Clinical Identification of Torsades de PointesBritish Journal of Pharmacology, 2006